7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide manufacturers
|
| | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Basic information |
| Product Name: | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide | | Synonyms: | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide;4-hydroxy-N N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-1H-benzimidazole-6-carboxamide;1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-;Tegoprazan Impurity 19;4-Hydroxy-N,N,2-trimethyl-1-tosylbenzimidazole-6-carboxamide;4-hydroxy-N,N, 2-trimethyl-1-p-toluenesulfonyl-1H-benzo [d] imidazole-6-formamide;N-Ts Tegoprazan parent nucleus;Tigola produced Impurity 19 | | CAS: | 942195-86-0 | | MF: | C18H19N3O4S | | MW: | 373.43 | | EINECS: | | | Product Categories: | | | Mol File: | 942195-86-0.mol | ![7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Structure](CAS/GIF/942195-86-0.gif) |
| | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Chemical Properties |
| Boiling point | 654.0±65.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C, sealed storage, away from moisture | | pka | 7.07±0.40(Predicted) | | Appearance | White to off-white Solid | | InChI | InChI=1S/C18H19N3O4S/c1-11-5-7-14(8-6-11)26(24,25)21-12(2)19-17-15(21)9-13(10-16(17)22)18(23)20(3)4/h5-10,22H,1-4H3 | | InChIKey | AGWVNJPTTKMUQO-UHFFFAOYSA-N | | SMILES | C1(C)N(S(C2=CC=C(C)C=C2)(=O)=O)C2=CC(C(N(C)C)=O)=CC(O)=C2N=1 |
| | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Usage And Synthesis |
| Uses | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide is mainly used in organic synthesis or pharmaceutical backbone materials. It can be used in the synthesis of benzimidazole derivatives as selective acid pump inhibitors for the treatment of conditions with antagonistic activity mediated by the acid pump, such as gastrointestinal disorders, gastro-oesophageal disorders, gastro-oesophageal reflux disease (GERD), laryngo-pharyngeal reflux disease, peptic ulcers, gastric ulcers, duodenal ulcers, and others. |
| | 7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide Preparation Products And Raw materials |
|